Skip to main content
Log in

In vitro susceptibility of quinolone-resistantCampylobacter jejuni to new macrolide antibiotics

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The MICs of erythromycin and three new macrolide antibiotics were determined for 36 quinolone-susceptible and 106 quinolone-resistantCampylobacter jejuni. The MIC90 values of azithromycin, clarithromycin, roxithromycin and erythromycin were 0.5, 4, 16 and 4 mg/l respectively. No difference was found between macrolide activity against the quinolone-susceptible and the quinolone-resistant strains. Clarithromycin and especially azithromycin might eventually replace erythromycin for the treatment ofCampylobacter jejuni infections in view of their pharmacological properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rademaker CMA, Hoepelman IM, Wolfhagen MJHM, Beumer H, Rozenberg-Arska M, Verhoef J Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travellers' diarrhea. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 690–694.

    Google Scholar 

  2. Wistrom J, Jertborn M, Hedstrom SA, Alestig K, Englund G, Jellheden B Short-term self-treatment of travellers' diarrhoea with norfloxacin: a placebo-controlled study. Journal of Antimicrobial Chemotherapy 1989, 23: 905–913.

    PubMed  Google Scholar 

  3. Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Ryden T, Mouton RP Quinolone-resistance inCampylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. Journal of Antimicrobial Chemotherapy 1991, 27: 199–208.

    PubMed  Google Scholar 

  4. Reina J, Alomar P Fluoroquinolone-resistance in thermophilicCampylobacter spp. isolated from stools of Spanish patients. Lancet 1990, ii: 186.

    Google Scholar 

  5. Rautelin H, Renkonen OV, Kosunen TU Emergence of fluoroquinolone-resistance inCampylobacter andCampylobacter coli in subjects from Finland. Antimicrobial Agents and Chemotherapy 1991, 35: 2065–2069.

    PubMed  Google Scholar 

  6. Gootz TD, Martin BA Characterization of high-level quinolone-resistance inCampylobacter. Antimicrobial Agents and Chemotherapy 1991, 35: 840–845.

    PubMed  Google Scholar 

  7. Kirst HA, Sides GD New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrobial Agents and Chemotherapy 1989, 33: 1419–1422.

    PubMed  Google Scholar 

  8. Kirst HA, Sides GD New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrobial Agents and Chemotherapy 1989, 33: 1413–1418.

    PubMed  Google Scholar 

  9. Smibert RM Campylobacter. In: Kreig NR, Holt JG (ed): Bergey's manual of systematic bacteriology. Volume 1. Williams & Wilkins, Baltimore, 1984, p. 111–118.

    Google Scholar 

  10. Mouton RP, van Klingeren B Standaardisatie van gevoeligheidsbepalingen, Supplement 2. RIVM, Bilthoven, The Netherlands, 1990, p. 42.

    Google Scholar 

  11. Taylor DE Antimicrobial resistance ofCampylobacter jejuni andCampylobacter coli to tetracycline, chloramphenicol, and erythromycin. In: Nachamkin I, Blaser MJ, Tompkins IS (ed):Campylobacter jejuni. American Society for Microbiology, Washington, DC, 1992, p. 74–86.

    Google Scholar 

  12. Karmali MA, de Grandis S, Flemming P Antimicrobial susceptibility ofCampylobacter with special reference to resistance patterns of Canadian isolates. Antimicrobial Agents and Chemotherapy 1981, 19: 593–597.

    PubMed  Google Scholar 

  13. Hirschl AM, Wolf D, Berger J, Rotter ML In vitro susceptibility ofCampylobacter jejuni andCampylobacter coli isolated in Austria to erythromycin and ciprofloxacin. International Journal of Medical Microbiology 1990, 272: 443–447.

    PubMed  Google Scholar 

  14. Vanhoof R, VanderLinden MP, Dierickx R, Lauwers S, Yourassowky E, Butzler JP Susceptibility ofCampylobacter fetus subsp.jejuni to twenty-nine antimicrobial agents. Antimicrobial Agents and Chemotherapy 1978, 14: 553–556.

    PubMed  Google Scholar 

  15. Svedhem A, Kaijser B, Sjögren E Antimicrobial susceptibility ofCampylobacter isolated from humans with diarrhoea and from healthy chickens. Journal of Antimicrobial Chemotherapy 1981, 7: 301–305.

    PubMed  Google Scholar 

  16. Taylor DE, Chang N In vitro susceptibilities ofCampylobacter andCampylobacter coli to azithromycin and erythromycin. Antimicrobial Agents and Chemotherapy 1991, 35: 1917–1918.

    PubMed  Google Scholar 

  17. Kitzis MD, Goldstein FW, Miégi M, Acar JF In vitro activity of azithromycin against various gram-negative bacilli and anaerobic bacteria. Journal of Antimicrobial Chemotherapy 1990, 25, Supplement B: 15–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endtz, H.P., Broeren, M. & Mouton, R.P. In vitro susceptibility of quinolone-resistantCampylobacter jejuni to new macrolide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 12, 48–50 (1993). https://doi.org/10.1007/BF01997058

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01997058

Keywords

Navigation